Effects of 24 Months of Growth Hormone (GH) Treatment on Serum Carboxylated and Undercarboxylated Osteocalcin Levels in GH-Deficient Adults

Calcified Tissue International

Volumn 74, Issue 1, 2004, Pages 55-59

  Hubina, E ^a   Lakatos, P ^b   Kovacs L ^a   Szabolcs, I ^a   Racz K ^c   Toth M ^c   Szucs N ^c   Goth M I ^a  

^a NATIONAL MEDICAL CENTER   (Hungary)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Bone mass; Growth hormone replacement; Undercarboxylated osteocalcin

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM PHOSPHATE; GROWTH HORMONE; OSTEOCALCIN; PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; BONE METABOLISM; BONE MINERAL; CARBOXYLATION; CLINICAL ARTICLE; FEMALE; FEMUR NECK; FRACTURE; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; LUMBAR SPINE; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGED; BONE AND BONES; BONE DENSITY; CARBOXYLIC ACIDS; FEMALE; GROWTH HORMONE; HORMONE REPLACEMENT THERAPY; HUMANS; HUNGARY; MALE; MIDDLE AGED; OSTEOCALCIN; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 0842283931     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-002-2149-4     Document Type: Article

References (39)

1. Cuneo RC, Salomon F, MacGauley GA, Sonksen PH (1992) The growth hormone deficiency syndrome in adults. Clin Endocrinol 37:387-397
2. Wuster C (1993) Growth hormone and bone. Acta Endocrinol 128:S14-S18
3. Rosen T, Hansson T, Granhed H, Szucs J, Bengtsson B-A (1993) Reduced bone mineral content in adult patients with growth hormone deficiency. Acta Endocrinol 129:201-206
4. de Boer H, Blok GJ, van Lingen A, Teule GJ, Lips P, van der Veen EA (1994) Consequences of childhood-onset growth hormone deficiency for adult bone mass. J Bone Miner Res 9:1319-1326
5. Melton LJ, Atkinson EJ, O'Fallon WM, Wahner HW, Riggs BL (1993) Long-term fracture prediction by bone mineral assessed at different skeletal sites. J Bone Miner Res 8:1227-1233
6. Rosen T, Wilhelmsen L, Landin-Wilhelmsen K, Lappas G, Bengtsson B-A (1997) Increased fracture frequency in adult patients with hypopituitarism and GH deficiency. Eur J Endocrinol 137:240-245
7. Wuster C (2000) Fracture rates in patients with growth hormone deficiency. Horm Res 54:31-35
8. Wuster C, Abs R, Bengtsson B-A, Bennmarker H, Feldt-Rasmussen U, Hernberg-Stahl E, Monson JP, Westberg B, Wilton P (2001) The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. J Bone Miner Res 16:398-405
9. Bengtsson B-A, Eden S, Lonn L, Kvist H, Stokland A, Lindstedt G, Bosaeus I, Tolli J, Sjostrom L, Isaksson OG (1993) Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 76:309-317
10. Rodriguez-Arnao J, James I, Jabbar A, Trainer PJ, Perrett D, Besser GM, Ross RJ (1998) Serum collagen crosslink as marker of bone turn-over during GH replacement therapy in growth hormone-deficient adults. Clin Endocrinol 48:455-462
11. Gomez JM, Gomez N, Fiter J, Soler J (2000) Effects of long-term treatment with GH in the bone mineral density of adults with hypopituitarism and GH deficiency and after discontinuation of GH replacement. Horm Metab Res 32:66-70
12. Schlemmer A, Johansen JS, Pedersen SA, Jorgensen JO, Hassager C, Christiansen C (1991) The effect of growth hormone (GH) therapy on urinary pyridinoline cross-links in GH-deficient adults. Clin Endocrinol 35:471-476
13. Binnerts A, Swart GR, Wilson JH, Hoogerbrugge N, Pols HA, Birkenhager JC, Lamberts SW (1992) The effect of growth hormone administration in growth hormone-deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition. Clin Endocrinol 37:79-87
14. Bianda TM, Glatz Y, Bouillon R, Froesch ER, Schmid C (1998) Effects of short-term insulin-like growth factor-I (IGF-I) or growth hormone (GH) treatment on bone metabolism and on production of 1, 25-dihydroxychole-calciferol in GH-deficient adults. J Clin Endocrinol Metab 83:81-87
15. Fernholm R, Bramnert M, Hagg E, Hilding A, Baylink DJ, Mohan S, Thoren M (2000) Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease. J Clin Endocrinol Metab 85:4104-4112
16. Whitehead HM, Boreham C, Mellrath EM, Sheridan B, Kennedy L, Atkinson AB, Hadden DR (1992) Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo-controlled crossover study. Clin Endocrinol 36:45-52
17. Bollerslev J, Moller J, Thomas S, Djoseland O, Christiansen JS (1996) Dose-dependent effects of recombinant human growth hormone on biochemical markers of bone and collagen metabolism in adult growth hormone deficiency. Eur J Endocrinol 135:666-671
18. Attanasio AF, Lamberts SW, Matranga AM, Birkett MA, Bates PC, Valk NK, Hilsted J, Bengtsson B-A, Strasburger CJ (1997) Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group. J Clin Endocrinol Metab 82:82-88
19. Sartorio A, Ortolani S, Galbiati E, Conte G, Vangeli V, Arosio M, Porretti S, Faglia G (2001) Effects of 12-month GH treatment on bone metabolism and bone mineral density in adults with adult-onset GH deficiency. J Endocrinol Invest 24:224-230
20. Bravenboer N, Holzmann P, de Boer H, Roos JC, van der Veen EA, Lips P (1997) The effect of growth hormone (GH) on histomorphometric indices of bone structure and bone turnover in GH-deficient men. J Clin Endocrinol Metab 82:1818-1822
21. Carroli PV, Christ ER, Bengtsson B-A, Carlsson L, Christiansen JS, Clemmons D, Hintz R, Ho K, Laron Z, Sizonenko P, Sonksen PH, Tanaka T, Thorner M (1998) Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. J Clin Endocrinol Metab 83:382-392
22. Ohlsson C, Bengtsson B-A, Isaksson OGP, Andreassen TT, Slootweg MC (1998) Growth hormone and bone. Endocr Rev 19:55-79
23. Seibel MJ, Robins SP, Bilezikian JP (1997) Serum undercarboxylated osteocalcin and the risk of hip fracture. J Clin Endocrinol Metab 82:717-718
24. Luukinen H, Kakonen SM, Pettersson K, Koski K, Laippala P, Lovgren T, Kivela SL, Vaananen HK (2000) Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin. J Bone Miner Res 15:247-248
25. Liu G, Peacock M (1998) Age-related changes in serum undercarboxylated osteocalcin and its relationships with bone density, bone quality, and hip fracture. Calcif Tissue Int 62:286-289
26. Sugiyama T, Kawai S (2001) Carboxylation of osteocalcin may be related to bone quality: a possible mechanism of bone fracture prevention by vitamin K. J Bone Miner Res 19:146-149
27. Szulc P, Chapuy MC, Meunier PJ, Delmas PD (1993) Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 91: 1769-1774
28. Szulc P, Arlot M, Chapuy MC, Duboeuf F, Meunier PJ, Delmas PD (1994) Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. J Bone Miner Res 9:1591-1595
29. Szulc P, Chapuy MC, Meunier PJ, Delmas PD (1996) Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three-year follow-up study. Bone 18:487-488
30. Merle B, Delmas PD (1990) Normal carboxylation of circulating osteocalcin (bone Gla-protein) in Paget's disease of bone. Bone Miner 11:237-245
31. Vergnaud P, Garnero P, Meunier PJ, Breatr G, Kamihagi K, Delmas PD (1997) Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study. J Clin Endocrinol Metab 82:719-724
32. Bengtsson B-A, Abs R, Bennmarker H, Monson JP, Feldt-Rasmussen U, Hernberg-Stahl E, Westberg B, Wilton P, Wuster C (1999) The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. J Clin Endocrinol Metab 76:309-317
33. Coopper C (1993) The epidemiology of fragility fractures: Is there a role for bone quality? Calcif Tissue Int 53:S23-S26
34. Schnitzler CM (1993) Bone quality: a determinant for certain risk factors for bone fragility. Calcif Tissue Int 53:S27-S31
35. Takahashi M, Naitou K, Ohishi T, Kushida K, Miura M (2001) Effect of vitamin K and/or D on undercarboxylated and intact osteocalcin in osteoporotic patients with vertebral or hip fractures. Clin Endocrinol 54:219-224
36. Gundberg CM, Nieman SD, Abrams S, Rosen H (1998) Vitamin K status and bone health: an analysis of methods for determination of undercarboxylated osteocalcin. J Clin Endocrinol Metab 83:3258-3266
37. Binkley NC, Krueger DC, Engelke JA, Foley AL, Suttie JW (2000) Vitamin K supplementation reduces serum concentration of under-γ-carboxylated osteocalcin in healthy young and elderly adults. Am J Clin Nutr 72:1523-1528
38. Knapen MH, Hellemons-Boode BS, Langenberg-Ledeboer M, Knottnerus JA, Hamulyak K, Price PA, Vermeer C (2000) Effect of oral anticoagulant treatment on markers for calcium and bone metabolism. Haemostasis 30:290-297
39. Zittermann A (2001) Effects of vitamin K on calcium and bone metabolism. Curr Opin Clin Nutr Metab Care 4: 483-487